The involvement of the OPG-RANKL-RANK axis may also be involved in the pathogenesis of metabolic diseases such as type II diabetes and its associated insulin resistance and metabolic syndrome, as well as non-alcoholic fatty liver disease (NAFLD) [41,42]. This evidence concerns the gene TNFSF11 and metabolic dysfunction-associated steatotic liver disease.